Category: news

Industry veteran CFO Frank Karbe brings more than 25 years of leadership experience in the biopharma industry transitioning companies from…

Reported encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with androgen receptor inhibitors in…

REDWOOD CITY, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient…

PRINCETON, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that…

CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused…

SOUTH SAN FRANCISCO, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a…

JENA, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics…

SAN CARLOS, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating,…

DURHAM, N.C., Feb. 18, 2025 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), today announced that on February 12, 2025, the Compensation Committee…

Legendary NFL running back Ricky Williams’ newest cannabis product delivers potency, convenience and affordability in every innovative puffBOSTON, Feb. 18,…